bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
Khresmoi - new !
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2018: D N O S A J J M A M F J
2017: D

  Health Highlights: Feb. 21, 2018

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:

Billy Graham Dead at Age 99

Evangelical Pastor Billy Graham died Wednesday at age 99.

His death was announced by officials of his organization, NBC News reported.

Graham grew up on a diary farm in North Carolina and started his spiritual journey at age 16 when he met traveling minister and temperance movement leader Mordecai Ham. Graham was ordained in Florida in 1939.

Along with preaching to about 200 million people in 185 countries, Graham served as counselor or minister to a dozen U.S. presidents, NBC News reported.

-----

Treatment for Severe Peanut Allergy Shows Promise in Company Study

An experimental treatment to reduce the risk of serious allergic reactions to peanuts yielded promising results in a study conducted by the company that developed the therapy.

The study included nearly 500 youngsters, ages 4-17, with severe peanut allergies. They took either capsules of peanut flour or a dummy (placebo) powder in steadily increasing quantities for six months, then kept taking that final level for another six months, the Associated Press reported.

By the end of the study, 67 percent of the participants who took the peanut flour were able to tolerate the equivalent of roughly two peanuts, compared with only 4 percent of those who took the placebo.

About 20 percent of participants in the peanut powder group dropped out of the study, 12 percent due to reactions or other problems, the AP reported.

The findings announced Tuesday by California-based Aimmune Therapeutics have not been reviewed by independent experts, but will be presented next month at a medical meeting.

The company plans to file for U.S. Food and Drug Administration approval of the therapy by the end of 2018, and for approval in Europe early next year. If approved, it would be the first such treatment available in the U.S.

Peanut allergies affect millions of children and can trigger life-threatening reactions in some, the AP reported.

Copyright © 2018 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=731292

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Hypersensitivity
Therapeutics
Affect
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact